🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Tecogen director John Hatsopoulos buys $3.4k in company shares

Published 24/04/2024, 16:44
TGEN
-

John Hatsopoulos, a director at Tecogen Inc . (NASDAQ:OTC:TGEN), a company specializing in air conditioning and heating equipment, has made a notable investment in the company's stock. On April 24, Hatsopoulos purchased 5,000 shares of Tecogen's common stock at a price of $0.6707 per share, totaling approximately $3,353.

This transaction reflects a vote of confidence in the firm from a key member of its board, as Hatsopoulos's investment increases his total holdings to 886,485 shares. The acquisition of these shares was carried out directly and is documented in the latest filing with the Securities and Exchange Commission.

Investors often monitor insider transactions like these as they can provide insights into the company's prospects as seen by those closest to its operations. The purchase by Hatsopoulos may be interpreted as a positive sign by market observers.

Tecogen, headquartered in Waltham, Massachusetts, is known for its industrial-grade equipment that serves a variety of commercial and residential applications. The company's stock trades on the NASDAQ stock exchange under the ticker symbol TGEN.

For those following Tecogen's market activity, this recent insider purchase could be a point of interest, as it represents a tangible action by a director who is further investing in the company he helps oversee.

InvestingPro Insights

Following the recent insider purchase by John Hatsopoulos, Tecogen Inc. (NASDAQ:TGEN) has seen some intriguing financial metrics that potential investors may find informative. As per the latest data, Tecogen's market capitalization stands at a modest $16.7 million, which could indicate a company with potential for growth, especially considering the InvestingPro Tips that analysts anticipate sales growth in the current year.

Moreover, the company's stock is known for high price volatility, which might appeal to certain investors looking for dynamic trading opportunities. Tecogen's financials also reveal that it has not been profitable over the last twelve months, with an adjusted P/E ratio of -3.68. This aligns with another InvestingPro Tip suggesting that analysts do not anticipate the company will be profitable this year.

The revenue growth for the last quarter of 2023 stands at a staggering 30.16%, a figure that might catch the eye of those looking for companies with a sharp increase in sales. Despite the lack of profitability, Tecogen maintains a gross profit margin of 40.58%, indicating a strong capability to convert sales into profit at the gross level. Additionally, it's important to note that the company does not pay a dividend, which may influence the investment strategy of income-focused shareholders.

For more detailed analysis and further InvestingPro Tips, including whether Tecogen operates with a moderate level of debt and how its liquid assets stack up against short-term obligations, interested parties can explore the additional 5 tips available on InvestingPro. Also, remember to use coupon code PRONEWS24 for an additional 10% off a yearly or biyearly Pro and Pro+ subscription to gain full access to these insights.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.